High-dose IVIG therapy in a child with idiopathic thrombocytopenic purpura associated with mumps

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 1, 2005, Pages 56-57

  Buyukavci, Mustafa ^a   Yildirim, Zuhal Keskin ^a   Tan, Huseyin ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

AMYLASE BLOOD LEVEL; BLOOD CELL COUNT; CASE REPORT; CHICKENPOX; CLINICAL FEATURE; CYTOMEGALOVIRUS; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; MUMPS; PARVOVIRUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RUBELLA VIRUS; SCHOOL CHILD; VIRUS ACTIVATION;

EID: 12944316393     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000151804.79843.c2     Document Type: Letter

References (5)

1. Montgomery RR, Scott JP. Hemorrhagic and thrombotic diseases. In: Behrman RE, Kliegman RM, Jenson HB, eds. Textbook of Pediatrics, 17th ed. Philadelphia: WB Saunders, 2004:1651-1674.
2. Yenicesu I, Yetgin S, Ozyurek E, et al. Virus-associated immune thrombocytopenic purpura in childhood. Pediatr Hematol Oncol. 2002;19:433-437.
3. Ninomiya N, Maeda T, Matsuda I. Thrombocytopenic purpura occurring during the early phase of a mumps infection. Helv Paediatr Acta. 1977;32:87-89.
4. Oner AF, Caksen H, Arslan S, et al. Use of intravenous megadose corticosteroid in a child-with thrombocytopenic purpura due to mumps. J Paediatr Child Health. 2001;37:525-526.
5. Benesch M, Kerbl R, Lackner H, et al. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol. 2003;25:797-800.